Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group.
JAMA. 1996 Feb 28;275(8):606-10. Unique Identifier : AIDSLINE MED/96174499 Mayaux MJ; Burgard M; Teglas JP; Cottalorda J; Krivine A; Simon F; Puel J; Tamalet C; Dormont D; Masquelier B; Doussin A; Rouzioux C; Blanche S; Institut National de la Sante et de la Recherche Medicale,; Hopital Bicetre, Le Kremlin-Bicetre, France.
Abstract:
OBJECTIVE: To identify clinical and laboratory parameters at birth that are associated with the rapidly progressive form of human immunodeficiency virus type 1 (HIV-1) disease in children born to infected mothers. DESIGN: Multicenter, prospective study of infants born to HIV-seropositive mothers. SETTING: A total of 62 obstetric and pediatric centers in France. PARTICIPANTS: Of 1386 children born to HIV-1-seropositive mothers at least 18 months before the cutoff date, 267 were infected. Infection was defined as serological positivity at 18 months or death from HIV disease before the age. MAIN OUTCOME MEASURE: Category C events (including opportunistic infections, recurrent severe bacterial infections, cancers, specific encephalopathy, and wasting syndrome) in the new pediatric Centers for Disease Control and Prevention classification during the first year of life, according to clinical, immunological, and virological findings at birth. RESULTS: The risk of category C manifestations at 12 months was significantly higher when an infected newborn had liver and/or spleen enlargement and/or adenopathies (38.1% vs 15.1%; relative risk [RR], 2.5; 95% confidence interval [CI], 1.4 to 6.0; P<.02) or a low proportion (<30%) of CD4+ cells at birth (45.5% vs 15.0%; RR, 3.0; 95% CI, 1.4 to 6.4; P<.005). Similarly, HIV-1 culture and/or polymerase chain reaction positivity during the first week of life was associated with a higher risk of the early, severe form of HIV infection (26.4% vs 9.3%; RR, 2.8; 95% CI, 1.3 to 6.1; P<.006). In case of positive antigenemia at birth, the risk was 50.0% vs 14.4% (RR, 3.5; 95% CI, 1.9 to 6.2; P<.001). These parameters, determined at birth, were strongly interrelated and could reflect active disease onset in utero in some cases of early, severe HIV-1 disease in childhood. CONCLUSIONS: These prognostic markers, particularly virological parameters, are of value in monitoring children infected by HIV and might serve as a basis for early therapeutic intervention.
Keywords: AIDS Serodiagnosis/METHODS Disease Progression Disease Transmission, Vertical Female Human HIV Infections/*CONGENITAL/DIAGNOSIS/PHYSIOPATHOLOGY/TRANSMISSION HIV Seropositivity/CONGENITAL/DIAGNOSIS/PHYSIOPATHOLOGY/ TRANSMISSION *HIV-1/ISOLATION & PURIF Infant Infant, Newborn Polymerase Chain Reaction Pregnancy Pregnancy Complications, Infectious/*VIROLOGY Prognosis Prospective Studies Severity of Illness Index Support, Non-U.S. Gov't Survival Analysis JOURNAL ARTICLE MULTICENTER STUDY
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
